Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry (v3.6.4) as the latest version, and the previous entry (v3.6.3) is removed from the current history view.
    Difference
    0.1%
    Check dated 2026-07-25T12:53:06.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the study record history, replacing the previous v3.6.2. This indicates a routine update to the page's revision tracking or rendering.
    Difference
    0.1%
    Check dated 2026-07-04T03:58:55.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-06-27T02:07:19.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.0) was added to the study history, introducing the verifier’s name (wang shusen) and updated last-verified metadata. The change strengthens the audit trail by clarifying who verified the record and which version is current.
    Difference
    3%
    Check dated 2026-06-12T16:12:46.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study record's revision history now includes a new entry for v3.5.5 and removes the previous v3.5.4 entry, updating the version history to reflect the latest submission.
    Difference
    0.1%
    Check dated 2026-06-05T11:54:08.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Revision tag in the page footer updated from v3.5.3 to v3.5.4, indicating a minor site version update rather than changes to the study record.
    Difference
    0.1%
    Check dated 2026-05-15T05:55:27.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.